Leukotriene B4 and lnterleukin-8 in Human Immunodeficiency Virus-related Pulmonary Disease

Murray, 1987, NHLBI workshop summary: pulmonary complications of the acquired immune deficiency syndrome: an update, Am Rev Respir Dis, 135, 504 Masur, 1989, Pneumocystis pneumonia: from bench to clinic, Ann Intern Med, 111, 813, 10.7326/0003-4819-111-10-813 Suffredini, 1987, Nonspecific interstitial pneumonitis: a common cause of pulmonary disease in the acquired immunodeficiency syndrome, Ann Intern Med, 107, 7, 10.7326/0003-4819-107-1-7 Ognibene, 1988, Nonspecific interstitial pneumonitis without evidence of Pneumocystis carinii in asymptomatic patients infected with human immunodeficiency virus (HIV), Ann Intern Med, 109, 874, 10.7326/0003-4819-109-11-874 Montaner, 1990, Oral corticosteroids prevent early deterioration in patients with moderately severe AIDS-related Pneumocystis carinii pneumonia, Ann Intern Med, 113, 14, 10.7326/0003-4819-113-1-14 Gagnon, 1990, Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: a double-blind, placebo-controlled trial, N Engl J Med, 323, 1444, 10.1056/NEJM199011223232103 Bozzette, 1990, A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome, N Engl J Med, 323, 1451, 10.1056/NEJM199011223232104 National Institutes of Health-University of California Expert Panel for Corticosteroids as Adjunctive Therapy for Pneumocystis Pneumonia, 1990, Consensus statement on the use of corticosteroids as adjunctive therapy for Pneumocystis pneumonia in the acquired immunodeficiency syndrome, N Engl J Med, 323, 1500, 10.1056/NEJM199011223232131 Mason, 1989, Prognostic implications of bronchoalveolar lavage neutrophilia in patients with Pneumocystis carinii pneumonia and AIDS, Am Rev Respir Dis, 139, 1336, 10.1164/ajrccm/139.6.1336 Colangelo, 1991, Follow-up bronchoalveolar lavage in AIDS patients with Pneumocystis carinü pneumonia: Pneumocystis carinii burden predicts early relapse, Am Rev Respir Dis, 143, 1067, 10.1164/ajrccm/143.5_Pt_1.1067 Speich, 1990, Prognostic score for Pneumocystis carinii pneumonia, Respiration, 57, 259, 10.1159/000195852 Jensen, 1991, Cellular profiles in bronchoalveolar lavage fluid of HIV-infected patients with pulmonary symptoms: relation to diagnosis and prognosis, AIDS, 5, 527, 10.1097/00002030-199105000-00008 Smith, 1988, Correlation of bronchoalveolar lavage cell populations with clinical severity of Pneumocystis carinii pneumonia, Chest, 93, 60, 10.1378/chest.93.1.60 Limper, 1989, Pneumocystis carinii pneumonia: Differences in lung parasite number and inflammation in patients with and without AIDS, Am Rev Respir Dis, 140, 1204, 10.1164/ajrccm/140.5.1204 Limper, 1990, Pneumocystis carinii: inhibition of lung cell growth mediated by parasite attachment, J Clin Invest, 85, 391, 10.1172/JCI114451 Israël-Biet, 1991, Tumor necrosis factor production in HIV-seropositive subjects, J Immunol, 147, 490 Millar, 1991, Production of tumor necrosis factor-A by blood and lung mononuclear phagocytes from patients with human immunodeficiency virus-related lung disease, Am J Respir Cell Mol Biol, 5, 144, 10.1165/ajrcmb/5.2.144 Agostini, 1991, Alveolar macrophages from patients with AIDS and AIDS-related complex constitutively synthesize and release tumor necrosis factor alpha, Am Rev Respir Dis, 144, 195, 10.1164/ajrccm/144.1.195 Krishnan, 1990, Alveolar macrophages in AIDS patients: increased spontaneous tumor necrosis factor-alpha production in Pneumocystis carinii pneumonia, Clin Exp Immunol, 80, 156, 10.1111/j.1365-2249.1990.tb05225.x Kernbaum, 1983, Phospholipase activities of bronchoalveolar lavage fluid in rat Pneumocystis carinii pneumonia, Br J Exp Pathol, 64, 75 Waite M. Phospholipases. In: Vance DE, Vance JE, eds. Biochemistry of lipids and membranes. Menlo Park, NJ: Benjamin/Cummings Publishing, 1985; 299-324 Koeniger, 1989, Serum activities of phospholipase A in acute post-traumatic pulmonary insufficiency, Klin Wochenschr, 67, 212, 10.1007/BF01711356 Offenstadt, 1981, Phospholipase and prophospholipase activities in bronchoalveolar lavage fluid in severe acute pulmonary disease with or without ARDS, Intensive Care Med, 7, 285, 10.1007/BF01709723 Martin, 1984, Leukotriene B4 production by the alveolar macrophage: a potential mechanism for amplifying inflammation in the lung, Am Rev Respir Dis, 129, 106 Ford-Hutchinson, 1980, Leukotriene B4, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes, Nature, 286, 264, 10.1038/286264a0 Martin, 1989, Effects of leukotriene B4 in the human lung, J Clin Invest, 84, 1609, 10.1172/JCI114338 Martin, 1987, Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophages, J Clin Invest, 80, 1114, 10.1172/JCI113168 Seeger, 1991, Omega-oxidized leukotriene B4 detected in the broncho-alveolar lavage fluid of patients with non-cardiogenic pulmonary edema, but not in those with cardiogenic edema, Intensive Care Med, 17, 1, 10.1007/BF01708400 Hopkins, 1989, Neutrophil chemotactic factors in bacterial pneumonia, Chest, 95, 1021, 10.1378/chest.95.5.1021 Garcia, 1989, Alveolar macrophages from patients with asbestos exposure release increased levels of leukotriene B4, Am Rev Respir Dis, 139, 1494, 10.1164/ajrccm/139.6.1494 Kunkel, 1991, Interleukin-8: the major neutrophil chemotactic factor in the lung, Exp Lung Res, 17, 17, 10.3109/01902149109063278 Peveri, 1988, A novel neutrophil-activating factor produced by human mononuclear phagocytes, J Exp Med, 167, 1547, 10.1084/jem.167.5.1547 Carré, 1991, Increased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis, J Clin Invest, 88, 1802, 10.1172/JCI115501 Ozaki, 1992, Neutrophil chemotactic factors in the respiratory tract of patients with chronic airway diseases or idiopathic pulmonary fibrosis, Am Rev Respir Dis, 145, 85, 10.1164/ajrccm/145.1.85 Ognibene, 1984, The diagnosis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome using subsegmental bronchoalveolar lavage, Am Rev Respir Dis, 129, 929 Travis, 1990, Atypical pathological manifestations of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome, Am J Surg Pathol, 14, 615, 10.1097/00000478-199007000-00002 Travis, 1992, Lymphoid pneumonitis in 50 adult patients infected with the human immunodeficiency virus: lymphocytic pneumonitis versus nonspecific interstitial pneumonitis, Hum Pathol, 23, 529, 10.1016/0046-8177(92)90130-U Doerfler, 1989, Bacterial lipopolysaccharides prime human neutrophils for enhanced production of leukotriene B4, J Clin Invest, 83, 970, 10.1172/JCI113983 Shak, 1987, Leukotriene B4 catabolism: quantitation of leukotriene B4 and its omega-oxidation products by reversed-phase high-performance liquid chromatography, Methods Enzymol, 141, 355, 10.1016/0076-6879(87)41083-5 Patriciarca, 1972, Phospholipases and phospholipid turnover in Escherichia coli spheroplasts, Biochim Biophys Acta, 260, 593, 10.1016/0005-2760(72)90008-2 Vadas, 1982, The efficacy of anti-inflammatory agents with respect to extracellular phospholipase A2 activity, Life Sci, 30, 155, 10.1016/0024-3205(82)90647-6 Hoffman, 1992, Reduction of pulmonary surfactant in patients with human immunodeficiency virus infection and Pneumocystis carinii pneumonia, Chest, 102, 1730, 10.1378/chest.102.6.1730 Edelson, 1991, Acute lung injury induced by phospholipase A2, Am Rev Respir Dis, 143, 1102, 10.1164/ajrccm/143.5_Pt_1.1102 Kovacs, 1990, Are corticosteroids beneficial as adjunctive therapy for Pneumocystis pneumonia in AIDS?, Ann Intern Med, 113, 1, 10.7326/0003-4819-113-1-1